소아용 의약품 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 예측 기간의 성장은 소아 인구 증가, 소아 정신 건강 문제의 유병률 증가, 만성 질환을 앓는 아동의 증가, 높은 예방 접종률, 소아 정신 건강 약물에 대한 수요 증가에 기인할 수 있습니다. 주요 트렌드에는 개인 맞춤형 소아 의학의 부상, 소아 약물 전달의 기술 발전, 원격 의료 및 디지털 건강 솔루션의 확대, 소아 임상시험의 강화, 소아과 의사와 약사 간의 협업 증가 등이 있습니다.
조산의 증가는 향후 몇 년간 소아용 의약품 시장의 성장을 견인할 것으로 예상됩니다. 조산은 일반적인 임신 기간인 40주보다 빠른 임신 37주 이전에 태어난 영아를 말합니다. 산모의 연령 증가, 라이프스타일 선택, 건강 상태, 다태 임신, 부적절한 산전 관리 등 여러 가지 요인이 조산의 증가에 영향을 미칩니다. 소아용 의약품은 호흡기 합병증, 감염, 영양 결핍과 같은 문제를 해결함으로써 미숙아의 건강과 발달을 지원하는 데 중요한 역할을 합니다. 예를 들어, 2022년 12월 영국의 자선 단체인 Tommy's가 발표한 보고서에 따르면 잉글랜드와 웨일즈의 조산아 출생 비율이 2021년 7.5%에서 2022년 7.9%로 증가했습니다. 이러한 증가로 인해 2022년에 조산아로 태어난 아기는 53,000명 이상 증가했습니다. 결과적으로 조산아의 증가는 소아과 의약품 시장의 확장을 촉진하고 있습니다.
소아용 의약품 시장의 주요 기업은 어린 환자의 치료 효과를 높이고 부작용을 줄이기 위해 완전 인간 단일 클론 항체와 같은 혁신적인 치료법을 개발하는 데 주력하고 있습니다. 완전 인간 단일 클론 항체(mAb)는 전적으로 인간의 유전자 서열에서 추출한 것으로 키메라 또는 인간화 단일 클론 항체에 비해 면역 반응의 위험을 최소화합니다. 이러한 항체는 인간 항체 유전자를 가진 형질전환 마우스 또는 파지 디스플레이 기술과 같은 첨단 생명공학 기술을 사용하여 생산됩니다. 예를 들어, 2022년 8월 미국 제약 회사인 Johnson & Johnson은 활동성 건선성 관절염(PsA)이 있는 6세 이상의 소아 환자를 치료하기 위해 스텔라라(우스테키누맙)에 대한 FDA 승인을 받았습니다. 스텔라라는 자가면역질환과 관련된 염증 반응에 중요한 역할을 하는 사이토카인인 인터루킨-12(IL-12)와 인터루킨-23(IL-23)을 표적으로 하는 최초이자 유일한 생물학적 치료제라는 점에서 이번 승인은 중요한 돌파구를 마련했다는 점에서 의미가 있습니다. 활성 PsA는 만성 염증성 관절염 어린이의 약 5-8%에 영향을 미치는 드문 질환으로 관절 부종 및 피부 병변과 같은 증상을 유발합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 소아용 의약품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 소아용 의약품 시장 : 성장률 분석
- 세계의 소아용 의약품 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 소아용 의약품 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 소아용 의약품 총 시장 규모(TAM)
제6장 시장 세분화
- 세계의 소아용 의약품 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 호흡기 질환 치료제
- 자가면역 질환 치료제
- 위장약
- 심혈관약
- 세계의 소아용 의약품 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 경구
- 국소
- 비경구
- 기타 투여 경로
- 세계의 소아용 의약품 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 온라인 약국
- 기타 유통 채널
- 세계의 소아용 의약품 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 전문 클리닉
- 홈케어
- 기타 최종 사용자
- 세계의 소아용 의약품 시장 : 호흡기 질환 치료제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 천식 치료제
- 낭포성 섬유증 치료제
- 기관지 확장제
- 코르티코스테로이드
- 세계의 소아용 의약품 시장 : 자가면역 질환 치료제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 면역 억제제
- 생물학적 치료
- 질병 조절 항류마티스 약물(DMARD)
- 세계의 소아용 의약품 시장 : 위장약 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 양성자 펌프 억제제(PPI)
- 구토 방지제
- 지사제
- 완하제
- 세계의 소아용 의약품 시장 : 심혈관약 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 항고혈압제
- 심부전 치료제
- 항부정맥제
- 지질 저하제
제7장 지역별 및 국가별 분석
- 세계의 소아용 의약품 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 소아용 의약품 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 소아용 의약품 시장 : 경쟁 구도
- 소아용 의약품 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Johnson & Johnson 개요, 제품 및 서비스, 전략 및 재무 분석
- Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Sanofi SA 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Bristol-Myers Squibb
- AstraZeneca Plc
- Novartis AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company
- Eli Lilly and Co.
- Gilead Sciences Inc.
- Amgen Inc.
- Teva Pharmaceutical Industries Ltd.
- Otsuka Pharmaceutical Co. Ltd.
- Vertex Pharmaceuticals
- UCB Pharma
- Sun Pharmaceutical Industries Ltd.
- Perrigo Company
- Shionogi & Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 소아용 의약품 시장(2029년) : 새로운 기회를 제공하는 국가
- 소아용 의약품 시장(2029년) : 새로운 기회를 제공하는 부문
- 소아용 의약품 시장(2029년) : 성장 전략
제36장 부록
HBR
Pediatric drugs are medications specifically formulated, dosed, and approved for use in infants, children, and adolescents. These drugs are designed to treat a wide range of medical conditions in pediatric patients, taking into account their unique physiological and metabolic differences from adults.
The primary types of pediatric drugs include respiratory disorder drugs, autoimmune disorder drugs, gastrointestinal drugs, and cardiovascular drugs. Respiratory disorder drugs are formulated to manage breathing-related conditions in children, such as asthma, cystic fibrosis, and respiratory syncytial virus (RSV). These medications can be administered through various routes, including oral, topical, and parenteral methods. They are distributed through multiple channels, such as hospital pharmacies, retail pharmacies, and online pharmacies. Pediatric drugs are utilized by various end users, including hospitals, specialty clinics, homecare settings, and other healthcare facilities.
The pediatric drugs market research report is one of a series of new reports from The Business Research Company that provides pediatric drugs market statistics, including the pediatric drugs industry global market size, regional shares, competitors with the pediatric drugs market share, detailed pediatric drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the pediatric drugs industry. This pediatric drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The pediatric drugs market size has grown rapidly in recent years. It will grow from $157.0 billion in 2024 to $181.02 billion in 2025 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to the rising demand for pediatric medications, a growing pediatric population, increased awareness of pediatric diseases, the expansion of pediatric oncology, the rise of digital health and telemedicine, and enhanced collaboration in pediatric drug development.
The pediatric drugs market size is expected to see rapid growth in the next few years. It will grow to $316.0 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to an increasing pediatric population, a rising prevalence of pediatric mental health issues, a growing number of children with chronic conditions, higher vaccination rates, and increasing demand for pediatric mental health medications. Major trends include the rise of personalized pediatric medicine, technological advancements in pediatric drug delivery, the expansion of telemedicine and digital health solutions, enhanced pediatric clinical trials, and increased collaboration between pediatricians and pharmacists.
The increasing number of preterm births is anticipated to drive the growth of the pediatric drugs market in the coming years. Preterm births refer to infants born before completing 37 weeks of gestation, which is earlier than the typical 40-week term. Several factors contribute to the rise in preterm births, including increased maternal age, lifestyle choices, medical conditions, multiple pregnancies, and inadequate prenatal care. Pediatric drugs play a crucial role in supporting the health and development of preterm infants by addressing challenges such as respiratory complications, infections, and nutritional deficiencies. For example, in December 2022, a report published by Tommy's, a UK-based charity organization, indicated that the percentage of premature live births in England and Wales increased to 7.9% in 2022, up from 7.5% in 2021. This rise accounted for more than 53,000 babies born prematurely in 2022. As a result, the growing number of preterm births is fueling the expansion of the pediatric drugs market.
Leading companies in the pediatric drugs market are focusing on developing innovative treatments, such as fully human monoclonal antibodies, to enhance therapeutic outcomes and reduce side effects for young patients. A fully human monoclonal antibody (mAb) is derived entirely from human genetic sequences, minimizing the risk of immune reactions compared to chimeric or humanized monoclonal antibodies. These antibodies are produced using advanced biotechnological techniques, such as transgenic mice with human antibody genes or phage display technology. For instance, in August 2022, Johnson & Johnson, a US-based pharmaceutical company, received FDA approval for STELARA (ustekinumab) to treat pediatric patients aged six years and older with active psoriatic arthritis (PsA). This approval marked a significant breakthrough, as STELARA is the first and only biologic therapy targeting interleukin-12 (IL-12) and interleukin-23 (IL-23), cytokines that play a key role in the inflammatory responses associated with autoimmune diseases. Active PsA is a rare condition that affects approximately 5-8% of children with chronic inflammatory arthritis, causing symptoms such as joint swelling and skin lesions.
In July 2022, JB Chemicals & Pharma Limited, an India-based pharmaceutical company, acquired four pediatric brands from Dr. Reddy's Laboratories for ₹98.3 crore (approximately $1.18 million). This acquisition was aimed at expanding JB Pharma's presence in the pediatric segment by leveraging the market leadership of the acquired brands to strengthen its portfolio and support future growth ambitions in India. Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company specializing in pediatric drug development.
Major players in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila.
North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pediatric drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pediatric drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pediatric drugs market consists of sales of antibiotics, vaccines, pediatric pain relief, respiratory medications, antihistamines, and pediatric dermatology products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pediatric Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pediatric drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pediatric drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pediatric drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Respiratory Disorder Drugs; Autoimmune Disorder Drugs; Gastrointestinal Drugs; Cardiovascular Drugs
- 2) By Route Of Administration: Oral; Topical; Parenteral; Other Route Of Administrations
- 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
- 4) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
- Subsegments:
- 1) By Respiratory Disorder Drugs: Asthma Medications; Cystic Fibrosis Treatments; Bronchodilators; Corticosteroids
- 2) By Autoimmune Disorder Drugs: Immunosuppressants; Biologic Therapies; Disease-Modifying Antirheumatic Drugs (DMARDs)
- 3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs); Antiemetics; Antidiarrheals; Laxatives
- 4) By Cardiovascular Drugs: Antihypertensive Medications; Heart Failure Treatments; Antiarrhythmic Drugs; Lipid-lowering Agents
- Companies Mentioned:Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; Bayer AG; Sanofi S.A.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Pediatric Drugs Market Characteristics
3. Pediatric Drugs Market Trends And Strategies
4. Pediatric Drugs Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Pediatric Drugs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Pediatric Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Pediatric Drugs Market Growth Rate Analysis
- 5.4. Global Pediatric Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Pediatric Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Pediatric Drugs Total Addressable Market (TAM)
6. Pediatric Drugs Market Segmentation
- 6.1. Global Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Respiratory Disorder Drugs
- Autoimmune Disorder Drugs
- Gastrointestinal Drugs
- Cardiovascular Drugs
- 6.2. Global Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Topical
- Parenteral
- Other Route Of Administrations
- 6.3. Global Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Other Distribution Channels
- 6.4. Global Pediatric Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Homecare
- Other End-Users
- 6.5. Global Pediatric Drugs Market, Sub-Segmentation Of Respiratory Disorder Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Asthma Medications
- Cystic Fibrosis Treatments
- Bronchodilators
- Corticosteroids
- 6.6. Global Pediatric Drugs Market, Sub-Segmentation Of Autoimmune Disorder Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immunosuppressants
- Biologic Therapies
- Disease-Modifying Antirheumatic Drugs (DMARDs)
- 6.7. Global Pediatric Drugs Market, Sub-Segmentation Of Gastrointestinal Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Proton Pump Inhibitors (PPIs)
- Antiemetics
- Antidiarrheals
- Laxatives
- 6.8. Global Pediatric Drugs Market, Sub-Segmentation Of Cardiovascular Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antihypertensive Medications
- Heart Failure Treatments
- Antiarrhythmic Drugs
- Lipid-lowering Agents
7. Pediatric Drugs Market Regional And Country Analysis
- 7.1. Global Pediatric Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Pediatric Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Pediatric Drugs Market
- 8.1. Asia-Pacific Pediatric Drugs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Pediatric Drugs Market
- 9.1. China Pediatric Drugs Market Overview
- 9.2. China Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Pediatric Drugs Market
- 10.1. India Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Pediatric Drugs Market
- 11.1. Japan Pediatric Drugs Market Overview
- 11.2. Japan Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Pediatric Drugs Market
- 12.1. Australia Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Pediatric Drugs Market
- 13.1. Indonesia Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Pediatric Drugs Market
- 14.1. South Korea Pediatric Drugs Market Overview
- 14.2. South Korea Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Pediatric Drugs Market
- 15.1. Western Europe Pediatric Drugs Market Overview
- 15.2. Western Europe Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Pediatric Drugs Market
- 16.1. UK Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Pediatric Drugs Market
- 17.1. Germany Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Pediatric Drugs Market
- 18.1. France Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Pediatric Drugs Market
- 19.1. Italy Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Pediatric Drugs Market
- 20.1. Spain Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Pediatric Drugs Market
- 21.1. Eastern Europe Pediatric Drugs Market Overview
- 21.2. Eastern Europe Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Pediatric Drugs Market
- 22.1. Russia Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Pediatric Drugs Market
- 23.1. North America Pediatric Drugs Market Overview
- 23.2. North America Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Pediatric Drugs Market
- 24.1. USA Pediatric Drugs Market Overview
- 24.2. USA Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Pediatric Drugs Market
- 25.1. Canada Pediatric Drugs Market Overview
- 25.2. Canada Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Pediatric Drugs Market
- 26.1. South America Pediatric Drugs Market Overview
- 26.2. South America Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Pediatric Drugs Market
- 27.1. Brazil Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Pediatric Drugs Market
- 28.1. Middle East Pediatric Drugs Market Overview
- 28.2. Middle East Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Pediatric Drugs Market
- 29.1. Africa Pediatric Drugs Market Overview
- 29.2. Africa Pediatric Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Pediatric Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Pediatric Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Pediatric Drugs Market Competitive Landscape And Company Profiles
- 30.1. Pediatric Drugs Market Competitive Landscape
- 30.2. Pediatric Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
31. Pediatric Drugs Market Other Major And Innovative Companies
- 31.1. Bristol-Myers Squibb
- 31.2. AstraZeneca Plc
- 31.3. Novartis AG
- 31.4. GlaxoSmithKline plc
- 31.5. Takeda Pharmaceutical Company
- 31.6. Eli Lilly and Co.
- 31.7. Gilead Sciences Inc.
- 31.8. Amgen Inc.
- 31.9. Teva Pharmaceutical Industries Ltd.
- 31.10. Otsuka Pharmaceutical Co. Ltd.
- 31.11. Vertex Pharmaceuticals
- 31.12. UCB Pharma
- 31.13. Sun Pharmaceutical Industries Ltd.
- 31.14. Perrigo Company
- 31.15. Shionogi & Co. Ltd.
32. Global Pediatric Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Pediatric Drugs Market
34. Recent Developments In The Pediatric Drugs Market
35. Pediatric Drugs Market High Potential Countries, Segments and Strategies
- 35.1 Pediatric Drugs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Pediatric Drugs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Pediatric Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
